Abiopharma

🔍 Taxay Marc (Executive)

Company: CADENCE DESIGN SYSTEMS INC (CDNS)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 973 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,938.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,460 shares of Common Stock (Direct)
  Date: 2026-03-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,398.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents Performance-Based Restricted Stock Units that have met the performance criteria, which vest on the first anniversary of the grant date subject to continued service.
• F2: Represents Performance-Based Restricted Stock Units that have met the performance criteria, which vest in three equal annual installments on the first, second and third anniversaries of the grant date subject to continued service.